AYOUB MARHOU | Medical physics| Young Scientist Award

Posted on by ScienceFather

Mr. AYOUB MARHOU | Medical physics| Young Scientist Award

Faculty of sciences, Mohammed first university Morocco

Marhou Ayoub, born on September 28, 1996, in Talsint, Morocco, is a dedicated Ph.D. candidate in Physics and Engineering at the Faculty of Sciences, Oujda. His expertise lies in theoretical physics and particle physics, driven by a strong academic background and research passion.

Professional Profile 

Education πŸŽ“

2024: Final year of Doctorate in Physics and Engineering, Faculty of Sciences, Oujda. 2019: Began Ph.D. in Theoretical Physics and Particle Physics. 2019: Master’s in Physics of Matter and Radiation, Faculty of Sciences, Oujda (Bien). 2017: Bachelor’s in Physics, Faculty of Sciences, Oujda (Bien). 2014: BaccalaurΓ©at, Experimental Sciences, Benitadjit (Passable).

Experience πŸ’»

2019: Radiotherapy internship (4 months), Hassan II Oncology Center, CHU Mohammed VI, Oujda. Proficient in Windows, Linux, UNIX, Microsoft Word, LibreOffice, and LaTeX2e. Skilled in programming languages: Fortran (learning), C, C++, and OOP. Expert in simulation tools like Geant4.

Awards and Honors πŸ…

  • Recognized for academic excellence in Master’s and Bachelor’s studies.
  • Active contributor to high-level physics research projects and simulations.

Research Focus πŸ”¬

Specializes in theoretical physics, particle physics, and radiation physics, emphasizing advanced computational simulations and programming to explore innovative solutions in physics and engineering.

Publications Top Noted

 

  1. The Impact Assessment of a Magnetic Field Dedicated to MRI During a Carbon-Therapy on Treatment Efficiency: Application to 1.5 T Magnetic Field
    • Authors: A. Marhou, A. Bazza, I. Habib-Allah, M. Zerfaoui, N. Chafi
    • Journal: Radiation Physics and Chemistry
    • Year: 2025
    • Volume: 227
    • Article ID: 112360
    • Citations: 0

 

  1. Assessment of Natural Radioactivity in Moroccan Bottled Drinking Waters Using Gamma Spectrometry
    • Authors: A. Bazza, M. Rhiyourhi, A. Marhou, M. Hamal
    • Journal: Environmental Monitoring and Assessment
    • Year: 2023
    • Volume: 195
    • Issue: 11
    • Article ID: 1307
    • Citations: 1

Yasaman Taslimi | diagnosis | Best Researcher Award

Posted on by ScienceFather

Dr. Yasaman Taslimi | diagnosis| Autonomous systems | Best Researcher Award

Dr, Pasteur institute of Iran, Iran

πŸ‘©β€πŸ”¬ Dedicated researcher with a Ph.D. in Biology from Pasteur Institute of Iran, specializing in molecular genetics and parasitology. 🧬 Skilled in molecular diagnostics and protein analysis for Leishmaniasis. Currently serving as a Researcher in Immunotherapy and Leishmania Vaccine Research at Pasteur Institute, with extensive teaching and visiting researcher experience globally.  Recognized for academic excellence with awards including first rank in Ph.D. studies. Passionate about advancing immunotherapy and infectious disease research, with notable presentations at international congresses and a diverse range of specialized courses attended.🌟

Profile

Scopus

Orcid

Scholar

 

Education πŸ“š

B.Sc. in Nutrition Azad University, Tehran, Iran 2000, M.Sc. in Biochemistry Azad University, Damghan, Iran 2015, PhD in Biology Pasteur Institute of Iran 2023

Position πŸ’Ό

  • Researcher in Immunotherapy and Leishmania Vaccine Research Department
    Pasteur Institute of Iran
    2000-Present

Area of Expertise 🧬

  • Molecular genetics, molecular parasitology, gene function and expression.
  • Molecular diagnosis of Leishmaniasis.
  • Arginase assay.
  • Protein analysis techniques such as Western Blot, Elisa.
  • PEA assay.
  • LAMP assay.

Courses πŸŽ“

Molecular DATA for infectious disease, ITM, Antwerp, Belgium, 2018International Workshop of Leishmania and Leishmaniasis, Pasteur Iran, 2016Molecular Biology of Leishmaniasis, ICGEB, Trieste, Italy, 2016.Targeting and Expression of Gene in Cells, International Congress of Immunology, Tehran, 2014How to write an International Article, Elsevier workshop, Tehran, 2014Application of Bioinformatics in Biotechnology, Pasteur Iran, 2013Flow Cytometry workshop, Pasteur Iran, 2012Quality Control Management, Pasteur Iran, 2012Calibration methods and standards, Pasteur Iran, 2011Life skills courses (Depression, Anger management, Time management, …), Pasteur, 2010Advanced Molecular Genetic course, Pasteur Iran, 2006ICDL courses, 2006

Teaching πŸ“

High throughput technologies in translational immunology, Pasteur, Iran, 2022Western Blot, Practical, School of Pharmacy, Shahid Beheshti University, Tehran, Iran, 2016Immunology of infectious disease, Practical, Pasteur Iran, 2006

Visiting Researcher 🌍

Gothenburg University (Leishild-MATI RISE project), Department of Microbiology and Immunology at Institute of Biomedicine, 2019/02/26-2019/05/14Pasteur Institute of Paris (Leishild-MATI RISE project), Department of Molecular Parasitology and Signaling, 2023/12/17-2023/02/17

Congress Presentations πŸ—£οΈ

International Congress of Dermatology, Cosmetics and Laser, Iran, Tehran, 2022.International congress of immunology, Iran, Ahvaz, 2021.The 17th International Congress of Immunology, Beijing, China, 2019.Molecular Biology of Leishmania course, Trieste, Italy, 2016.Annual Symposium of the Institut Pasteur International Network, Paris, 2015.6th Worldleish international congress, Toledo, Spain, 2017.

Awards πŸ†

The Second National Conference on New Cellular and Molecular, Iran, 2015.13th International Congress of Immunology and Allergy of Iran, Tabriz, 2015.First ranked Ph.D. student in Pasteur Institute of Iran, 2018.

Publications Top Notes πŸ“

  1. Title: Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis
    Authors: A Zadeh-Vakili, T Taheri, Y Taslimi, F Doustdari, AH Salmanian, S Rafati
    Journal: Vaccine
    Volume: 22
    Issue: 15-16
    Pages: 1930-1940
    Year: 2004
    Citations: 81

 

  1. Title: Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen
    Authors: F Zahedifard, E Gholami, T Taheri, Y Taslimi, F Doustdari, N Seyed, …
    Journal: PLoS neglected tropical diseases
    Volume: 8
    Issue: 3
    Pages: e2751
    Year: 2014
    Citations: 79

 

  1. Title: Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
    Authors: N Saljoughian, T Taheri, F Zahedifard, Y Taslimi, F Doustdari, …
    Journal: PLoS neglected tropical diseases
    Volume: 7
    Issue: 4
    Pages: e2174
    Year: 2013
    Citations: 75

 

  1. Title: Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral …
    Authors: S Rafati, E Gholami, N Hassani, F Ghaemimanesh, Y Taslimi, T Taheri, …
    Journal: Vaccine
    Volume: 25
    Issue: 21
    Pages: 4159-4169
    Year: 2007
    Citations: 71

 

  1. Title: Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals
    Authors: N Khoshgoo, F Zahedifard, H Azizi, Y Taslimi, MJ Alonso, S Rafati
    Journal: Vaccine
    Volume: 26
    Issue: 46
    Pages: 5822-5829
    Year: 2008
    Citations: 61